Does New Zealand have an innovation system for biotechnology?

Abstract

While there is a large and growing international literature on economic aspects of biotechnology innovation (for example, work by Carlsson, McKelvey, Orsenigo, Zucker and Darby) these studies concentrate on the United States and Europe. The New Zealand biotechnology industry may be expected to develop along a different trajectory as a consequence of a markedly different set of initial and framework conditions. This paper presents the results of an ongoing study that aims to fill some of the gaps in our knowledge of innovation processes in New Zealand while using the international literature as a benchmark. The size and structure of modern biotech activity in New Zealand is described and compared to other OECD countries using biotech patent data and results from the New Zealand and Canadian biotechnology surveys.The paper then focuses on factors affecting innovation in biotechnology; framework conditions, government policy R&D funding and the role of networks and other linkages.

Innovation networks and capability building in the Australian high‐technology SMEs

“…Strategic alliances and other collaborative agreements among universities, biotechnology firms, and larger industrial companies (including pharmaceutical companies) are widely used methods of achieving innovation. The ways in which partner companies combine their resources to achieve innovation and the key determinants of successful innovation efforts in biotechnology have been the focus of recent research (McKelvey et al , 2003; Marsh, 2003).…”

The Changing Role of Research and Education in New Zealand Universities

“…The universities need to forge winning partnerships for commercial use of university research, which is currently confined only to some select sectors such as biotechnology. Government programmes have been generous in supporting the development of biotechnology, information and communication technologies and creative industry sectors (Marsh, 2003). Universities need to look beyond traditional academic areas and look for ways to address issues that are important for small and medium businesses outside these focused areas.…”

The problem of private under-investment in innovation: A policy mind map

“…The literature on National Systems of Innovation (NSIs) regularly stresses the importance of mature and welldeveloped capital markets for the allocation of financial resources to innovatin activities. To give a few examples, Edquist (2005) and O'Sullivan (2005) offer comprehensive general surveys, while Chang and Shih (2004) compare the distinct systems of China and Taiwan, or Marsh (2003) investigates the particular case of the biotech industry in New Zealand.…”